Abstract -The replication of porcine reproductive and respiratory syndrome virus (PRRSV) in lungs and lymphoid tissues of PRRSV-infected pigs is already strongly reduced before the appearance of neutralizing antibodies, indicating that other immune mechanisms are involved in eliminating PRRSV at those sites. This study aimed to determine whether PRRSV Lelystad virus (LV)-specific cytotoxic T-lymphocytes (CTL) can efficiently eliminate PRRSV-infected alveolar macrophages. Therefore, CTL assays were performed with PRRSV-infected alveolar macrophages as target cells and autologous peripheral blood mononuclear cells (PBMC) from PRRSV-infected pigs as a source of PRRSV-specific CTL. PBMC of 3 PRRSV-infected pigs were used either directly in CTL assays, or following restimulation in vitro. CTL assays with pseudorabies virus (PRV) Begonia-infected alveolar macrophages and autologous PBMC, from 2 PRV Begoniainoculated pigs, were performed for validation of the assays. In freshly isolated PBMC, derived from PRRSV-infected pigs, CTL activity towards PRRSV-infected macrophages was not detected until the end of the experiment (56 days post infection -dpi). Restimulating the PBMC with PRRSV in vitro resulted in proliferation of CD3 + CD8 high cells starting from 14 dpi. Although CD3 + CD8 high cells are generally considered to be CTL, CTL activity was not detected in PRRSV-restimulated PBMC of the 3 pigs until 49 dpi. A weak PRRSV-specific CTL activity was observed only at 56 dpi in PRRSV-restimulated PBMC of one pig. In contrast, a clear CTL activity was observed in PRV Begonia-restimulated PBMC, derived from PRV Begonia-infected pigs, starting from 21 dpi. This study indicates that PBMC of PRRSV-infected pigs contain proliferating CD3 + CD8 high cells upon restimulation in vitro, but these PBMC fail to exert CTL activity towards PRRSV-infected alveolar macrophages.
INTRODUCTION
Porcine reproductive and respiratory syndrome (PRRS) is characterized by reproductive failure in sows and is associated with the respiratory disease complex affecting pigs of all ages [14, 59, 60] . The causative agent, PRRS virus (PRRSV), belongs to the family Arteriviridae, order Nidovirales [10] . In vivo, the virus infects subsets of pig macrophages that are mainly present in lungs and lymphoid tissues [20] . The pathogenesis of PRRSV infection is characterized by a high level of viremia for 1 to 2 weeks, followed by a low level of viremia for another 2 to 3 weeks. Subsequently, low levels of PRRSV may persist in lymphoid tissues for This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any noncommercial medium, provided the original work is properly cited.
several months [4, 20, 62] , but finally, PRRSV is eliminated from most pigs within 2 to 4 months [4, 20, 31, 62] . Up till now, it is not fully elucidated which immune mechanisms cause (i) a drop in virus replication in lungs and lymphoid tissues after 2 weeks of infection, (ii) complete elimination of the virus from the blood after 4 to 5 weeks of infection and (iii) complete elimination of the virus from the lungs and lymphoid tissues within 2 to 4 months.
PRRSV elicits an immune response that differs from the immune response induced by other viral swine pathogens like swine influenza virus or pseudorabies virus (PRV). PRRSVspecific non-neutralizing antibodies are quickly induced starting from 7 days post infection (dpi), but low titres of virus-neutralizing antibodies are only detected starting from 25-35 dpi [31, 37] . In some pigs, low levels of PRRSV replication are still found in lungs and lymphoid tissues in the presence of neutralizing antibodies [31] , indicating that other immune mechanisms are involved in the complete elimination of PRRSV at those sites. The adaptive cell-mediated immune response is described to play a critical role in the resolution of many virus infections and is exerted by cytotoxic T-lymphocytes (CTL) and T helper (Th) lymphocytes, in cooperation with Th1-activated natural killer cells (NK) and macrophages. PRRSV infection induces T-lymphocyte mediated immune responses starting from 2 to 4 weeks pi, as assessed by in vitro proliferation assays, in vitro IFNc ELISPOT assays and in vivo delayed type hypersensitivity assays [7, 8, 36, 41] . An inversed correlation has been described between the number of CD3 + CD8 high cells and PRRSV persistence in lymphoid organs [32] . Therefore, it has been suggested that CTL may play an important role in the reduction of virus replication in lungs and lymphoid tissue after 2 weeks of infection and in the complete clearance of PRRSV infection after 2 to 4 months. However, the contribution of the CTL in the elimination of PRRSVinfected cells has never been investigated. This study aimed to determine whether PRRSVspecific CTL are able to eliminate PRRSVinfected macrophages.
MATERIALS AND METHODS

Viruses
A 5th passage of PRRSV Lelystad virus (LV) [59, 60] on specific-pathogen-free alveolar macrophages was used for experimental inoculations of pigs. A 13th passage of LV on alveolar macrophages was used for in vitro restimulation of peripheral blood mononuclear cells (PBMC) and for in vitro inoculation of target cells. A PRV vaccine strain was included in this study for validation of the tests: a 2nd passage on swine testicle (ST) cells of PRV Begonia [57] was used for experimental inoculations of pigs, for in vitro restimulation of PBMC and for in vitro inoculation of target cells.
Animals and experimental design
Five 6-week-old pigs from a PRV-and PRRSVnegative farm were used. Alveolar macrophages were collected from each pig, by performing in vivo lung lavages. Briefly, the pigs were completely anesthetized (mixture of Zoletil-100, Virbac Animal Health, Barneveld, Netherlands; and Xyl-M 2%, VMD, Arendonk, Belgium) and a 40 cm catheter (3 mm diameter) was carefully slid through the trachea into a lung lobe. Lungs were lavaged with phosphatebuffered saline (PBS, 37°C) and the cells obtained were mainly macrophages (> 90%). The macrophages were aliquoted and stored in liquid N 2 until use. At 13 weeks of age, 3 pigs (pigs 1, 2 and 3) were inoculated oronasally with LV (2 · 10 6 TCID 50 in 8 mL PBS). Two pigs (pigs 4 and 5) were oronasally inoculated with PRV Begonia (2 · 10 7 TCID 50 in 8 mL PBS). Blood was sampled at 0, 1, 3, 6, 9, 14, 21, 28, 35, 42, 49 and 56 dpi for collection of serum and/or isolation of PBMC. In this study, only a small number of pigs was used for both ethical aspects and the large amount of parameters that had to be examined at the same time. The experiments were approved by the Ethical and Animal welfare Committee of the Faculty of Veterinary Medicine of Ghent University (EC2007/097).
Virus isolation and titration and serological examination
Virus was isolated and titrated from serum or nasal swabs on alveolar macrophages (PRRSV; pigs 1, 2 and 3) or ST cells (PRV Begonia; pigs 4 and 5).
Heat-inactivated sera were tested for the presence of antibodies against PRRSV (pigs 1, 2 and 3) or PRV Begonia (pigs 4 and 5) in an immunoperoxidase monolayer assay (IPMA) as described by Wensvoort et al. [59] on respectively methanol-fixed PRRSVinfected Marc-145 cells and methanol-fixed PRV Begonia-infected ST cells. In addition, the sera were tested for the presence of virus-neutralizing antibodies as described by Labarque et al. [31] for PRRSV, and as described by Andries et al. [5] for PRV.
Isolation and culture of PBMC
for proliferation assays and CTL assays PBMC were purified by density centrifugation over Ficoll-Paque (Pharmacia Biotech, Roosendaal, Netherlands). The cells obtained were either paraformaldehyde-fixed for examining proportions of CD3 +
CD8
high cells, either directly used in CTL assays or exposed to recall antigen (virus) in vitro (restimulation) to expand in vivo-primed virus-specific lymphocytes. Prior to restimulation, PBMC were adjusted to a concentration of 4 · 10 6 viable cells/mL medium and seeded in upright 75 cm 2 flasks. The medium consisted of a 1:1 mixture of AIM-V serum-free lymphocyte medium (Gibco, Merelbeke, Belgium) and RPMI 1640 medium, supplemented with foetal bovine serum (10%), L-glutamine (2 mM), non-essential amino acids (50 lM each), sodium pyruvate (500 lM), 2-mercaptoethanol (55 lM), gentamicin (50 lg/ mL), penicillin (100 U/mL), streptomycin (100 lg/ mL). PBMC were restimulated by adding semi-purified 
high cells, or used as a source of effector cells in CTL assays.
Lymphocyte proliferation assay
After 5 days of restimulation with virus or mock-control, PBMC were cytocentrifuged, paraformaldehyde-fixed and permeabilized with 0.1% Triton X-100. In vitro proliferation of in vivo-primed virusspecific CD8 high cells was determined by immunofluorescence stainings for both Ki-67 and CD8 antigens. Ki-67 is a short-living nuclear non-histone protein of which the expression is strictly associated with cell proliferation [24] . In short, cell smears were incubated with mAb MONX10284 (Monosan, Uden, Netherlands) directed against Ki-67 and with TexasRed-labeled goat anti-mouse IgG (Molecular Probes, Merelbeke, Belgium). Free goat anti-mouse binding sites were blocked with 10% mouse serum in PBS. Next, cell smears were incubated with FITC-labeled anti-CD8a mAb (76-2-11; Becton Dickinson PharMingen, Erembodegem, Belgium). The stainings were analyzed by fluorescence microscopy. For each condition, at least 2000 PBMC were analyzed. Generally, a CD8 high phenotype is considered to be specific for CTL [46] . Therefore, PBMC that were positive for both CD8 high and Ki-67 were considered as proliferating CTL. 0 -dioctadecyloxacarbocyanine (Dio, Invitrogen). Preliminary analysis showed that this membrane marker had no effect on cell viability and virus replication. At 7 hpi, viable macrophages were counted and used as autologous target cells in the CTL assays. The percentage of PRRSV-positive macrophages varied between 30 and 60%; the percentage of PRV Begonia-positive macrophages varied between 70 and 80%.
Effector cells
Viable PBMC were counted and used as a source of effector cells. PBMC were either used immediately Impairment of PRRSV-specific CD3 + CD8 high cells Vet. Res. (2009) 40:46 after isolation, or after restimulation with virus for 6 days.
CTL assay
Dio-labeled virus-infected alveolar macrophages were seeded in 96-well plates together with serial dilutions of autologous effector cells so that effector:target (E:T) ratios 100:1, 30:1, 0:1 were achieved. Experiments were performed in triplicate. After 4 h of incubation at 37°C, cell death was assessed at a single cell level: dead cells were labeled with ethidium bromide monoazide (EMA, Invitrogen), a fluorescent vital dye; the cells were fixed with paraformaldehyde and permeabilized with 0.1% saponin (Sigma). Virus-infected cells were stained with biotinylated PRRSV-specific polyclonal antibodies [15] or biotinylated PRV-specific polyclonal antibodies [22] and Alexafluor350-labeled streptavidin (Molecular Probes). Dead (EMA-positive) virus-infected target cells were counted using fluorescence microscopy. Cytolytic activity was calculated by subtracting the percentage of dead virus-infected target cells at E:T ratio 0:1 from the percentage of dead virus-infected target cells at E:T ratio's 100:1 or 30:1. MHC-I-restriction of lysis was assessed in two ways: (i) CTL assays were performed with heterologous alveolar macrophages derived by lung lavages of a non-related pig and (ii) CTL assays were performed with virus-infected target cells that were incubated for 30 min on ice with mAb directed against MHC-I (50 lg/mL; PT85A, VMRD Inc., Pullman, WA, USA) prior to the CTL assay. The isotype-matched anti-PCV2 mAb 16G12 [34] was used as isotype control in the MHC-I-blocking assay. PRRSV-specificity of observed cytotoxic activity was assessed in CTL assays with PBMC of the PRRSV-infected pigs and autologous alveolar macrophages that were in vitro inoculated with PRV Begonia instead of PRRSV. Similarly, PRV Begoniaspecific cytotoxic activity was determined in CTL assays with PBMC of the PRV Begonia-infected pigs and autologous macrophages that were in vitro infected with PRRSV.
Determination of IFNc production by virusor mock-restimulated PBMC derived from virus-infected pigs
The supernatant fluids of mock-and virusrestimulated PBMC (6 days of restimulation) were collected for determination of IFNc levels. Therefore, a commercially available IFNc ELISA (Biosource, Merelbeke, Belgium) was used.
RESULTS
Detection of viremia and humoral immune
response following exposure to PRRSV or PRV Begonia
As shown in Figure 1 , infectious PRRSV was detected in serum of the 3 PRRSV-inoculated pigs until 14 (pigs 2 and 3) or 21 (pig 1) dpi. On day 9 pi, all 3 PRRSV-infected pigs had seroconverted for PRRSV as shown by IPMA. PRRSV-neutralizing antibodies were detected starting from 21 (pig 3) or 28 (pigs 1 and 2) dpi. PRV Begonia could not be isolated from the PRV Begonia-inoculated pigs, neither from serum, nor from nasal swabs, though the PRV Begonia-inoculated pigs seroconverted for PRV Begonia at 9 dpi and PRV Begoniaspecific neutralizing antibodies were also detected starting from 9 dpi.
CTL assay with freshly isolated PBMC
At 0, 7, 14, 21, 28, 35, 42, 49 and 56 dpi, only negligible levels of cytolytic activity (not more than 4.6% lysis, average of 3 pigs) towards autologous PRRSV-infected alveolar macrophages were detected in freshly isolated PBMC derived from PRRSV-infected pigs (data not shown). Similar levels of lysis were observed when PRRSV-infected heterologous macrophages or PRV Begonia-infected autologous macrophages were used in the CTL assays (data not shown), indicating that the low level of cytolytic activity was not MHC-I-restricted and not specific for PRRSV.
Similarly, freshly isolated PBMC, derived from PRV Begonia-infected pigs at 0, 7, 14, 21, 28, 35, 42, 49 and 56 dpi poorly (not more than 6.4% lysis) and non-specifically lysed PRV Begonia-infected macrophages in a non-MHC-I-restricted way (data not shown). Since a virus-specific CTL activity was not detected in freshly isolated PBMC, neither for PRRSV, nor for PRV Begonia, PBMC were restimulated in vitro prior to the CTL assay. high cells), with the exception of pig 3 at 42 dpi. Restimulation of the PBMC with PRRSV resulted in a CD8 high cell proliferation response starting from 14 dpi. This proliferation response increased starting from 42 dpi until the end of the experiment (respectively 3.8%, 4.2% high cells at 42, 49 and 56 dpi). In the cultures of PRRSV-restimulated PBMC, PRRSV-infected monocytes seemed to be responsible for the presentation of PRRSV antigens via MHC-I towards PRRSV-specific CD8 high cells, since (i) at day 1 of the restimulation, 1 to 2% of the monocytes was infected with PRRSV; and (ii) restimulation of the PBMC with UV-inactivated PRRSV resulted only in background CD8 high cell proliferation levels (0.5 to 0.9%; data not shown).
The CD8 high cell proliferation response appeared to be PRRSV-specific, since restimulation with PRV Begonia only resulted in background CD8 high cell proliferation levels (0. high cells starting from 14 dpi compared to mock-restimulation (Fig. 3A) .
PRV Begonia restimulation of PBMC derived from PRV Begonia-infected pigs resulted in an increased percentage of CD3 + CD8
high cells starting from 7 dpi, compared to mock-restimulation (Fig. 3B). 3.5. CTL assay with virus-restimulated PBMC Figure 4 shows the percentages of lysed virus-infected target cells at an E:T ratio of 100:1. PRRSV-restimulated PBMC derived from PRRSV-infected pigs possessed no 
considerable levels of cytolytic activity towards PRRSV-infected autologous macrophages (2.0 to 8.9% average lysis of 3 pigs). To evaluate the MHC-I-restriction and the virus-specificity of this low level of cytolysis, 3 controls were used: CTL assays with PRRSV-infected heterologous macrophages, CTL assays with autologous macrophages that were incubated with anti-MHC-I mAb or its isotype control and CTL assays with PRV Begonia-infected autologous macrophages. Compared to each other, these control assays revealed similar levels of target cell lysis, indicating that the negligible levels of lysis were non-MHC-I-restricted and not virus-specific. Only at 56 dpi, a low level of PRRSV-specific, MHC-I-restricted cytotoxicity towards PRRSV-infected macrophages was detected in PRRSV-restimulated PBMC of one pig (pig 1).
In contrast, PRV Begonia-restimulated PBMC derived from PRV Begonia-infected pigs lysed PRV Begonia-infected autologous macrophages efficiently (14.5 to 28.1% average lysis of two pigs) starting from 21 dpi. Cytotoxicity towards PRV Begonia-infected autologous macrophages was considerably higher than cytotoxicity towards PRV Begonia-infected heterologous macrophages and than cytotoxicity towards PRV Begonia-infected autologous target cells, incubated with anti-MHC-I mAb. In addition, cytotoxicity towards PRV Begoniainfected autologous macrophages was higher than cytotoxicity towards PRRSV-infected autologous target cells. This indicates that PRV Begonia-restimulated PBMC possess cytolytic activity towards PRV begonia-infected macrophages in a MHC-I-restricted and virusspecific way.
Production of IFNc by virus-and mockrestimulated PBMC derived from virusinfected pigs
In addition to cytolytic activity, the production of IFNc by virus-and mock-restimulated PBMC was also examined. Mock-restimulated PBMC derived from PRRSV-inoculated pigs at 0 to 56 dpi, produced negligible amounts of IFNc (Fig. 5) . The average amount of IFNc produced by PRRSV-restimulated PBMC derived from PRRSV-infected pigs at 0 dpi was remarkably high (726 pg per 4 · 10 6 cells) compared to the average amount of IFNc produced by PRV Begonia-restimulated PBMC derived from the PRV Begonia-infected pigs at 0 dpi (193 pg per 4 · 10 6 cells). This high average value was caused by the high IFNc production of the PBMC of pigs 1 and 2 (both 1 040 pg per 4 · 10 6 cells). The general IFNc production was strongly reduced at later time points until the end of the experiment, except for pig 1, whose PBMC still produced high amounts of IFNc at 7 dpi, and again at 56 dpi. Mock-restimulated PBMC derived from PRV Begonia-inoculated pigs at 0 to 56 dpi produced negligible amounts of IFNc. PRV Begoniarestimulated PBMC derived from PRVinoculated pigs produced IFNc at all examined time points. The highest IFNc levels were produced by restimulated PBMC that were isolated from the pigs at 21 and 28 dpi (respectively 392.0 and 521.5 pg per 4 · 10 6 cells).
DISCUSSION
PRRSV replicates to high levels in lungs and lymphoid tissues, resulting in an extensive viremia during 2 weeks. Afterwards, the virus replicates at low levels for several weeks more. In some pigs, virus may persist for months, despite the presence of neutralizing antibodies [7, 31] . Until now, the role of CTL in the control of PRRSV replication was not investigated. In this study, CTL assays were performed with freshly isolated or PRRSV-restimulated PBMC derived from PRRSV-infected pigs as source of PRRSV-specific CTL and autologous PRRSVinfected alveolar macrophages as target cells.
Previously, Kawashima et al. [28] reported an increased number of CD8 + T-lymphocytes in periarteriolar lymphoid sheets of the spleen and in the paracortex of superficial inguinal lymph nodes of PRRSV-infected pigs, starting from 10 dpi. Other studies describe an influx of CD8 + T-lymphocytes in the blood, lungs and medial retropharyngeal lymph nodes of infected pigs, starting from 10 to 24 dpi [3, 33, 49, 50] . This suggests that PRRSVspecific CD8 + T-lymphocytes migrate from lymphoid sites of initial activation to sites of antigen deposition. Upon infection with PRRSV, an increased proportion of CD3 + CD8
high cells in freshly isolated PBMC was also observed in this study (data not shown), but CTL activity towards PRRSV-infected macrophages was not detected in these freshly isolated PBMC (data not shown). CTL activity was also not detected in freshly isolated PBMC derived from PRV Begoniainfected pigs in accordance with a study of De Bruin et al. [16] . Most likely, this is due to a low number of virus-specific CTL in the peripheral blood at the time points of blood collection [16, 21] . The sample time point appears to be a critical factor for the detection of direct CTL effector activity in the peripheral blood, since specific effector CTL are present in the blood for only a short period of time (own observation by B. Goddeeris).
Restimulating PBMC, derived from PRRSV-infected pigs, with PRRSV in vitro resulted in proliferation of CD8 high cells starting from 14 dpi, and in an increased proportion of CD3 + CD8
high cells. However, PRRSVspecific MHC-I-restricted cytolytic activity towards PRRSV-infected macrophages was not detected in these PBMC, except for pig 1 at 56 dpi. In contrast, PRV Begonia-restimulated PBMC derived from PRV Begonia-infected pigs possessed a clear CTL activity towards PRV Begonia-infected macrophages, which proves the well-functioning of the CTL assay technique used. Different hypotheses can be formulated to explain the observed lack of CTL activity: either (i) PRRSV-infected macrophages are not recognized by CTL, or (ii) PRRSV-infected macrophages are resistant to CTL-mediated lysis, or (iii) the responding CD3 + CD8
high cells are not PRRSV-specific CTL, or (iv) PRRSV-specific CTL are functionally impaired.
CTL recognize virus-infected cells via surface MHC-I molecules carrying viral peptides. In order to escape CTL-mediated lysis, many viruses have evolved strategies to interfere with the MHC-I pathway [26] . In this study, downregulation of surface MHC-I molecules was not observed in PRRSV-positive macrophages (data not shown). However, whether PRRSV peptides were loaded onto the MHC-I molecules was not determined.
CTL eliminate their target cells by inducing apoptosis via the death receptor-mediated and/ or the granzyme-mediated apoptosis pathway. Many viruses have developed strategies to interfere with these apoptosis pathways to protect infected cells against CTL-mediated elimination [6] . In this study, PRRSV-infected target cells were susceptible to lytic activity exerted by PRV Begonia-restimulated PBMC derived from PRV Begonia-infected pigs. This suggests that PRRSV-infected macrophages are not resistant to death receptor and/or granzymeinduced apoptosis, since it demonstrates susceptibility of PRRSV-infected macrophages towards NK activity, which is also exerted via death receptor and/or granzyme-induced apoptosis [27] .
It cannot be excluded that the proliferating CD3 + CD8
high cells that were only detected upon restimulation with PRRSV, are not PRRSV-specific CTL. In vitro restimulation with PRRSV induced CD4 + T-lymphocyte proliferation (7 to 15% proliferating CD4 + cells; data not shown), which may have induced aspecific cytokine-mediated proliferation of CD3 + CD8
high cells as a bystander effect [54] . It is also possible that the observed proliferating CD3 + CD8
high cells are PRRSV-specific CTL, but with an impaired effector function. Functional impairment of CTL is a common viral immune evasion mechanism and several virus-mediated mechanisms causing CTL impairment have been described [1, 9, 25, 30, 39, 43, 45, 47, 64] . Dendritic cells, which are the most important antigen-presenting cells, play a crucial role in the activation of naïve CTL [27] . Some viruses, like herpes simplex virus-1, human cytomegalovirus and hepatitis B virus, can render dendritic cells ineffective in stimulating T-lymphocytes [9, 43, 47] . Recent in vitro studies show that PRRSV replicates in certain subsets of dendritic cells, downregulates MHC-I, MHC-II and CD80/CD86 surface expression in these cells and induces dendritic cell apoptosis and necrosis at the end of the replication cycle [11, 23, 38, 58] . Up till now, it is not known whether these findings also account for the in vivo situation. Nevertheless, they suggest that PRRSV impairs the dendritic cell-mediated antigen-presenting function towards naïve CD8 + T-lymphocytes, which may result in an aberrant stimulation of naïve CD8 + T-lymphocytes and an aberrant CTL development. In addition to antigen and co-stimulation, CD8 + T-lymphocytes require cytokines like IFNa and IL12 for optimal generation of effector and memory cells [42] . However, PRRSV replication does not induce or even suppresses significant IFNa production [2, 56] , which also might contribute to an aberrant CTL development. CTL impairment can also be caused by the continuous presence of viral antigen and the consequent continuous activation of virusspecific immune cells which results in functional exhaustion or even physical depletion of virus-specific CTL clones [61, 64] , or in a general CTL suppression by the induction of regulatory T-lymphocytes [39, 48, 55] . PRRSV can persist in PRRSV-infected pigs for several months [4, 20, 31, 62] , thereby possibly stimulating PRRSV-specific immune cells for an extended period. Similarly to what is observed in chronic lymphocytic choriomeningitis virus and human immunodeficiency virus infections [30, 64] , it is possible that virus-specific proliferating, but regulatory T-lymphocyte-mediated functionally impaired CD3 + CD8
high cells are also present during PRRSV infection. This hypothesis is in agreement with the recently described PRRSV-mediated induction of regulatory T-lymphocytes [51] , and by the fact that PRRSV stimulates the production of IL10 [11-13, 19, 23, 52, 53] , which is known to be involved in the induction of regulatory T-lymphocytes [35] .
In this study, CTL activity was not detected in PBMC of pigs that were infected with the PRRSV LV strain. It is known that different PRRSV strains may induce differences in immune responses [19, 29, 40] . Whether the observations made in this study also account for PRRSV strains that are different from LV, remains to be determined.
Upon virus infection, the host immune response is generally directed into a Th1 response that is specialized in eliminating intracellular pathogens [27] . One of the key cytokines of a Th1 response is IFNc, which is produced by innate immune effector cells like NK, cd T-lymphocytes and macrophages, and by cells of the adaptive immunity, like CD4 Th1 lymphocytes, CTL and memory lymphocytes [27] . At 0 dpi, clear IFNc levels were detected in supernatants of both PRRSVrestimulated PBMC of pigs 1 and 2, and in PRV Begonia-restimulated PBMC of pigs 4 and 5. Surprisingly, the IFNc levels were higher for pigs 1 and 2 than for pigs 4 and 5. It is unlikely that the high IFNc level is caused by PRRSV, since PRRSV restimulation of PBMC of pig 4 did not result in high IFNc levels. Most probably, the initial high IFNc levels are rather due to host-associated factors. After 14 dpi, only negligible levels of IFNc were detected in supernatants of PRRSV-restimulated PBMC of PRRSV-infected pigs, except for pig 1 at 56 dpi, whereas clear IFNc levels were observed in supernatants of PRV Begoniarestimulated PBMC of PRV Begonia-infected pigs. The lack of CTL activity and the lack of IFNc production in PRRSV-restimulated PBMC derived from PRRSV-infected pigs suggest an impaired Th1 response upon infection with PRRSV. Our data support previous reports on PRRSV-induced cell-mediated immunity in which only low frequencies of PRRSV-specific IFNc-secreting cells were detected in PBMC of PRRSV-infected pigs during the first 2 months pi [7, 18, 41, 63] .
The role of the PRRSV-specific cellmediated immune response in the final resolution of PRRSV infection remains unclear. Some studies indicate that the PRRSV-specific cell-mediated immunity, as assessed by IFNcsecreting cells, has the potential to protect pigs from PRRSV infection [65] . However, the lack of CTL activity detection does not support the idea of an important role of PRRSV-specific CTL in the clearance of PRRSV infection. It is likely that the present in vitro findings also count for the in vivo situation, since PRRSVpositive cells are still present in lungs of PRRSV-infected pigs at 35 dpi despite a clear CD3 +
CD8
high influx in the lungs starting from 10 dpi [31, 49] . The functionality of PRRSVspecific CTL might be restored at later time points, e.g. once the virus load has declined beyond a certain threshold, as described previously [64] . In accordance with this, Meier et al. [41] demonstrated that higher levels of PRRSVspecific IFNc-secreting cells only appeared starting from 25 weeks pi. The CTL activity and IFNc production that were observed in pig 1 at 56 dpi also support this assumption.
Most likely, besides PRRSV-neutralizing antibodies and PRRSV-specific CTL, other (immune) mechanisms are involved in controlling and clearing PRRSV infection. PRRSV-restimulated PBMC of pig 1 possessed virus-non-specific and non-MHC-I-restricted cytolytic activity at 0 and 7 dpi and produced high levels of IFNc at those time points. Most likely, the cytolytic activity and the IFNc production were caused by innate immune effector cells, like NK cells or cd T-lymphocytes, in PBMC of that pig. Starting from day 0 pi until the end of the experiment, freshly isolated PBMC of pig 1 possessed 10 to 20% more cd T-lymphocytes than the other two PRRSVinfected pigs (data not shown). Whether cd T-lymphocytes were responsible for the cytotoxic effect and the IFNc production in vitro was not investigated but some data in this study, such as an inversed correlation between viremia and the amount of cd T-lymphocytes in freshly isolated PBMC (data not shown), support this assumption. Several studies also suggest a role for the cd T-lymphocyte-mediated non-MHC-I-restricted cytolytic activity in resolution of PRRSV infection [7, 36, 44] . However, up till now, there is no sufficient evidence to consolidate this.
In the present study, proliferation of CD3 + CD8
high cells was induced in PBMC upon restimulation with PRRSV. However, neither PRRSV-specific CTL activity, nor IFNc production was detected in these PBMC, indicating that the PBMC did not possess PRRSV-specific CTL activity. It remains to be determined whether there is PRRSV-specific CTL activity in vivo, but functional impairment or absence of PRRSV-specific CTL in vivo may play a role in the prolonged presence of PRRSV in its host. [21] Even C., Rowland R.R., Plagemann P.G., Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection, J. Virol. (1995) 69:5666-5676.
[22] Favoreel H.W., Nauwynck H.J., Van Oostveldt P., Mettenleiter T.C., Pensaert M.B., Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells, J. Virol. (1997) 71:8254-8261.
